⭐ Top Story
MSO Consolidation Surge: Big Players Lock In Market Share for Q3 2026
By Sheeba M. | May 18, 2026 MSO Consolidation Surge: Big Players Lock In Market Share for Q3 2026 TL;DR: Mega-cap MSOs are accelerating M&A
Canopy Growth Signals Turnaround as Q1 2026 Revenue Stabilizes
By Sheeba M. | May 15, 2026 Canopy Growth Signals Turnaround as Q1 2026 Revenue Stabilizes TL;DR: Canopy Growth’s Q1 2026 earnings show stabilized revenue
Green Thumb Industries Positions as the Dividend Play in Cannabis
By Sheeba M. | May 14, 2026 Green Thumb Industries Positions as the Dividend Play in Cannabis TL;DR: GTI’s strategic shift toward EBITDA margins and
📈 Top Movers

Supply Chain Pressures Hit Cannabis Prices in Q2
By Sheeba M. | May 5, 2026 Supply Chain Pressures Hit Cannabis Prices in Q2 TL;DR: Cannabis wholesale prices declined 8% across major markets as

Cannabis ETFs Rally on Licensing Expansion
By Sheeba M. | May 5, 2026 Cannabis ETFs Rally on Licensing Expansion TL;DR: Major cannabis ETFs surged 3.2% this week as state licensing boards

Cultivation Oversupply: Q2 Harvests Signal Market Softness Ahead
By Sheeba M. | May 5, 2026 Cultivation Oversupply: Q2 Harvests Signal Market Softness Ahead TL;DR: Early May harvests show 12% increase in cannabis supply
📰 Today's News
Hemp-Derived Cannabinoids: The $2B Unregulated Market Wall Street Is Watching
By Sheeba M. | May 19, 2026 Hemp-Derived Cannabinoids: The $2B Unregulated Market Wall Street Is Watching TL;DR: Delta-8, Delta-10, and HHC are generating estimated
Cannabis Real Estate Crunch: Why Cultivation Margins Are Tightening
By Sheeba M. | May 19, 2026 Cannabis Real Estate Crunch: Why Cultivation Margins Are Tightening TL;DR: Rising lease rates and zoning restrictions are squeezing
Hemp-Derived Boom: $3B Unregulated Market Forces FDA Reckoning
By Sheeba M. | May 19, 2026 Hemp-Derived Boom: $3B Unregulated Market Forces FDA Reckoning TL;DR: Delta-8, Delta-10, and HHC sales hit $3B annually. FDA’s
Trulieve’s Q2 Test: Can TRUL Defend Market Share Against Curaleaf?
By Sheeba M. | May 19, 2026 Trulieve’s Q2 Test: Can TRUL Defend Market Share Against Curaleaf? TL;DR: Trulieve reports Q2 earnings this week. Investor
Cannabis M&A Heats Up: Curaleaf Leads $5B Consolidation Sprint
By Sheeba M. | May 19, 2026 Cannabis M&A Heats Up: Curaleaf Leads $5B Consolidation Sprint TL;DR: Curaleaf signals aggressive Q2 M&A with $180M deal
Cannabis Tax Reform: $2B Relief Package Signals Sector Tailwind
By Sheeba M. | May 19, 2026 Cannabis Tax Reform: $2B Relief Package Signals Sector Tailwind TL;DR: Senate Finance Committee advances $2B tax relief package